M. Siegsmund

1.2k total citations
38 papers, 959 citations indexed

About

M. Siegsmund is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, M. Siegsmund has authored 38 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 8 papers in Oncology. Recurrent topics in M. Siegsmund's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Bladder and Urothelial Cancer Treatments (7 papers). M. Siegsmund is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Bladder and Urothelial Cancer Treatments (7 papers). M. Siegsmund collaborates with scholars based in Germany, United States and Netherlands. M. Siegsmund's co-authors include P. Alken, Ira Pastan, Matthias May, Hitoshi Yamazaki, V. Loy, P. Braun, Francisco Portillo, K.U. Köhrmann, Sven Gunia and B. Hoschke and has published in prestigious journals such as Journal of the American Society of Nephrology, The Journal of Urology and European Urology.

In The Last Decade

M. Siegsmund

37 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Siegsmund Germany 16 429 394 234 201 184 38 959
John M. Goldberg United States 11 285 0.7× 711 1.8× 131 0.6× 76 0.4× 212 1.2× 25 1.3k
Toshimichi Miya Japan 16 405 0.9× 574 1.5× 116 0.5× 119 0.6× 292 1.6× 42 968
Anders Riegels Knudsen Denmark 16 381 0.9× 279 0.7× 150 0.6× 257 1.3× 183 1.0× 58 953
A N Békássy Sweden 17 101 0.2× 305 0.8× 209 0.9× 144 0.7× 239 1.3× 31 1.4k
Clemens Grupp Germany 15 135 0.3× 199 0.5× 221 0.9× 159 0.8× 258 1.4× 49 857
Mihatsch Mj Switzerland 18 113 0.3× 125 0.3× 208 0.9× 221 1.1× 202 1.1× 64 1.1k
Jerold Napier United States 5 179 0.4× 328 0.8× 42 0.2× 187 0.9× 68 0.4× 6 747
Sadhna Dhingra United States 18 290 0.7× 153 0.4× 39 0.2× 305 1.5× 187 1.0× 58 965
Shinji Kishi Japan 14 98 0.2× 226 0.6× 323 1.4× 72 0.4× 310 1.7× 55 967
A. Joseph Brough United States 19 337 0.8× 115 0.3× 184 0.8× 363 1.8× 386 2.1× 37 1.4k

Countries citing papers authored by M. Siegsmund

Since Specialization
Citations

This map shows the geographic impact of M. Siegsmund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Siegsmund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Siegsmund more than expected).

Fields of papers citing papers by M. Siegsmund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Siegsmund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Siegsmund. The network helps show where M. Siegsmund may publish in the future.

Co-authorship network of co-authors of M. Siegsmund

This figure shows the co-authorship network connecting the top 25 collaborators of M. Siegsmund. A scholar is included among the top collaborators of M. Siegsmund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Siegsmund. M. Siegsmund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
May, Matthias, et al.. (2007). Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy. Scandinavian Journal of Urology and Nephrology. 41(5). 375–381. 33 indexed citations
2.
May, Matthias, K.-P. Braun, Wiltrud Richter, et al.. (2007). Stellen wir die Indikation zur radikalen Zystektomie immer zeitgerecht?. Der Urologe. 46(8). 913–919. 4 indexed citations
3.
4.
Gunia, Sven, M. Siegsmund, O. Kaufmann, et al.. (2006). Testikulärer Keimzelltumor und Sarkoidose. Der Urologe. 45(9). 1176–1180. 4 indexed citations
5.
May, Matthias, Sven Gunia, C. Helke, et al.. (2006). How Far Is the Preoperative Kattan Nomogram Applicable for the Prediction of Recurrence after Prostatectomy in Patients Presenting with PSA Levels of More than 20 ng/ml?. Urologia Internationalis. 77(3). 222–226. 5 indexed citations
6.
May, Matthias, et al.. (2006). Visual estimation of the tumor volume in prostate cancer: a useful means for predicting biochemical-free survival after radical prostatectomy?. Prostate Cancer and Prostatic Diseases. 10(1). 66–71. 22 indexed citations
7.
Grobholz, Rainer, et al.. (2005). Regressive Veränderungen nach kurzzeitiger neoadjuvanter antiandrogener Therapie beim Prostatakarzinom. Der Pathologe. 27(1). 33–39. 2 indexed citations
8.
Lohr, Frank, M. Fuß, U. Tiefenbacher, et al.. (2004). Optimierter Einsatz der Strahlentherapie durch IMRT und Pr�zisionslokalisationsverfahren bei der Behandlung des fortgeschrittenen Prostatakarzinoms. Der Urologe. 43(1). 43–51. 12 indexed citations
9.
Häcker, A., Martin Hatzinger, Thomas Knoll, et al.. (2003). Metachroner Hodentumor eines extragonadalen Keimzelltumors. Aktuelle Urologie. 34(6). 413–415. 2 indexed citations
10.
Siegsmund, M., Ulrich Brinkmann, Gregor Weirich, et al.. (2002). Association of the P-Glycoprotein Transporter MDR1 C3435T Polymorphism with the Susceptibility to Renal Epithelial Tumors. Journal of the American Society of Nephrology. 13(7). 1847–1854. 210 indexed citations
11.
Spahn, Martin, et al.. (2001). Color Duplex Sonography vs. Computed Tomography: Accuracy in the Preoperative Evaluation of Renal Cell Carcinoma. European Urology. 40(3). 337–342. 12 indexed citations
12.
Siegsmund, M., et al.. (2001). Die LDR-Brachytherapie, eine minimal invasive Alternative in der Therapie des organbegrenzten Prostatakarzinoms. Oncology Research and Treatment. 24(5). 46–50. 1 indexed citations
13.
Grobholz, Rainer, et al.. (2000). Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma. Pathology - Research and Practice. 196(5). 277–284. 38 indexed citations
14.
Siegsmund, M., et al.. (1999). Expression of the gene for the multidrug resistance-associated protein in human prostate tissue. Urological Research. 27(3). 164–168. 6 indexed citations
15.
Siegsmund, M., Claudia Marx, Othmar Seemann, et al.. (1999). Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins. Urological Research. 27(3). 157–163. 32 indexed citations
16.
Siegsmund, M., et al.. (1997). Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein. Urological Research. 25(1). 35–42. 17 indexed citations
17.
Köhrmann, K.U., et al.. (1997). Enhanced in vitro Cytotoxicity ofIdarubicin Compared to Epirubicinand Doxorubicin in Rat ProstateCarcinoma Cells. European Urology. 31(3). 365–370. 4 indexed citations
18.
Nichterlein, Thomas, M. Kretschmar, M. Siegsmund, & H. Hof. (1995). Erythromycin Is Ineffective AgainstListeria monocytogenesin Multidrug Resistant Cells. Journal of Chemotherapy. 7(3). 184–188. 8 indexed citations
19.
Seemann, O., et al.. (1995). Establishment and characterization of a multidrug-resistant human bladder carcinoma cell line RT112/D21. Urological Research. 22(6). 353–360. 6 indexed citations
20.
Siegsmund, M., et al.. (1990). [Doppler ultrasound of penis arteries].. PubMed. 29(3). 113–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Goldberg Breakdown of academic impact, for papers by Toshimichi Miya Breakdown of academic impact, for papers by Anders Riegels Knudsen Breakdown of academic impact, for papers by A N Békássy Breakdown of academic impact, for papers by Clemens Grupp Breakdown of academic impact, for papers by Mihatsch Mj Breakdown of academic impact, for papers by Jerold Napier Breakdown of academic impact, for papers by Sadhna Dhingra Breakdown of academic impact, for papers by Shinji Kishi Breakdown of academic impact, for papers by A. Joseph Brough
Rankless by CCL
2026